Table 1.

Main clinical characteristics of all affected subjects

Case	Gender	Age (years)	Age of onset (years)	Mean lesion size (mm)	Out of the face location	Confluence of adjacent lesions	Presence of BCC	Associated inflammatory process
IV-1	F	33	1	4	yes	yes	no	yes
IV-2	M	18	3	3	no	yes	no	no
III-1	M	56	10	7	yes	yes	yes	yes
III-2	M	45	13	5	yes	yes	no	no
II-1	M	92	18	8	yes	no	no	no
III-16	F	69	7	5	yes	yes	yes	yes
IV-9	F	35	13	3	no	yes	no	no
IV-11	M	50	?	5	no	yes	no	no
IV-12	M	31	?	5	no	yes	no	no
V-6	F	29	8	4	yes	yes	yes	no
III-17	F	72	12	10	yes	yes	yes	yes
IV-21	M	46	9	3	yes	yes	yes	yes
IV-16	F	49	10	3	yes	yes	yes	yes
V-7	M	25	14	2	no	no	no	no
IV-17	F	40	?	3	no	yes	no	no
IV-18	M	51	10	2	yes	yes	yes	yes
V-9	M	29	?	3	no	no	no	no
V-12	M	27	6	2	no	no	no	no
V-20	M	18	15	2	yes	no	no	yes
V-15	F	15	12	3	no	no	no	no
IV-24	F	44	21	2	no	yes	no	no
V-27	M	27	?	3	yes	yes	no	no
III-9	F	43	?	4	no	yes	no	no
III-10	M	41	10	3	yes	yes	no	no
Total men	14	39.7 (19.6)†	10.8 (4.4)†	3.8 (1.9)†	8 (57.1%)‡	9 (64.3%)‡	3 (21.4%)‡	4 (28.6%)‡
Total women	10	42.9 (17.3)†	10.5 (5.7)†	4.1 (2.2)†	5 (50%)‡	9 (90%)‡	4 (40%)‡	4 (40%)‡

?, unavailable; BCC, basal cell carcinoma; †, mean (standard deviation); ‡, number of “yes” (percentage inside gender)